Mersana announces management changes

09/29/2010 | Mass High Tech (Boston)

Mersana Therapeutics has selected Nicholas Bacopoulos, a biotech industry veteran who has been on the company's board since 2007, to serve as its president and chief executive. The company, which uses a bio-inert polymer technology in drug development, also has appointed its former CEO Julie Olson as chief technology officer.

View Full Article in:

Mass High Tech (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care